Transition to first episode psychosis in ultra high risk populations: Does baseline functioning hold the key?

Schizophrenia Research

Volumn 143, Issue 1, 2013, Pages 132-137

  Velthorst, Eva ^a   Nelson, Barnaby ^b   Wiltink, Suzanne ^b   de Haan, Lieuwe ^a   Wood, Stephen J ^c,d   Lin, Ashleigh ^c   Yung, Alison R ^b,e  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; DISEASE ASSOCIATION; FEMALE; FUNCTIONAL DISEASE; FUNCTIONAL STATUS; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOSIS; RISK ASSESSMENT; RISK FACTOR; SYMPTOMATOLOGY; ULTRA HIGH RISK POPULATION;

EID: 84871931751     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.10.025     Document Type: Article

References (20)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington DC.
2. Berger G., Wood S.J., Ross M., Hamer C., Wellard R.M., Pell G., Phillips L., Nelson B., Amminger G.P., Yung A.R., Jackson G., Velakoulis D., Manji H., McGorry P.D. Neuroprotective effects of low dose lithium in individuals at ultra-high risk for psychosis: a longitudinal MRI/MRS study. Curr. Pharm. Des. 2012, 18(4):570-575.
3. Cannon T.D., Cadenhead K., Cornblatt B., Woods S.W., Addington J., Walker E., Seidman L.J., Perkins D., Tsuang M., McGlashan T., Heinssen R. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch. Gen. Psychiatry 2008, 65(1):28-37.
4. Cornblatt B.A., Auther A.M., Niendam T., Smith C.W., Zinberg J., Bearden C.E., Cannon T.D. Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia. Schizophr. Bull. 2007, 33(3):688-702.
5. Cornblatt B.A., Carrión R.E., Addington J., Seidman L., Walker E.F., Cannon T.D., Cadenhead K.S., McGlashan T.H., Perkins D.O., Tsuang M.T., Woods S.W., Heinssen R., Lencz T. Risk factors for psychosis: impaired social and role functioning. Schizophr. Bull. 2012, 38(6):1247-1257.
6. First M.B., Gibbon M., Spitzer R.L., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders 1997, American Psychiatric Publishing, Inc., Arlington.
7. Heinrichs D.W., Hanlon T.E., Carpenter W.T. The quality of life scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr. Bull. 1984, 10(3):388-398.
8. Kelleher I., Murtagh A., Molloy C., Roddy S., Clarke M.C., Harley M., Cannon M. Identification and characterization of prodromal risk syndromes in young adolescents in the community: a population-based clinical interview study. Schizophr. Bull. 2012, 38(2):239-246.
9. Lin A., Wood S.J., Nelson B., Brewer W.J., Spiliotacopoulos D., Bruxner A., Broussard C., Pantelis C., Yung A.R. Neurocognitive predictors of functional outcome two to 13years after identification as ultra-high risk for psychosis. Schizophr. Res. 2011, 132(1):1-7.
10. McGorry P.D., Yung A.R., Phillips L.J., Yuen H.P., Francey S., Cosgrave E.M., Germano D., Bravin J., McDonald T., Blair A., Adlard S., Jackson H. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch. Gen. Psychiatry 2002, 59(10):921-928.
11. Mueser K.T., McGurk S.R. Schizophrenia. Lancet 2004, 363(9426):2063-2072.
12. Pantelis C., Yucel M., Wood S.J., McGorry P.D., Velakoulis D. Early and late neurodevelopmental disturbances in schizophrenia and their functional consequences. Aust. N. Z. J. Psychiatry 2003, 37(4):399-406.
13. Philips L.J., Nelson B., Yuen H.P., Francey S.M., Simmons F.M., Stanford C., Ross M., Kelly D., Baker K., Conus P., Amminger P., Trumpler F., Yun Y., Lim M., McNab C., Yung A.R., McGorry P.D. Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: part 1: study design and baseline characteristics. Aust. N. Z. J. Psychiatry 2009, 43(9):818-829.
14. Schimmelmanm B.G., Michel C., Schaffner N., Schultze-Lutter F. What percentage of people in the general population satisfies the current clinical at-risk criteria of psychosis?. Schizophr. Res. 2011, 125(1):99-100.
15. Üstün T.B., Rehm J., Chatterji S., Saxena S., Trotter R., Room R., Bickenbach J. Multiple-informant ranking of the disabling effects of different health conditions in 14 countries. Lancet 1999, 354(9173):111-115. and the WHO/NIH Joint Project CAR Study Group.
16. Velthorst E., Nieman D.H., Linszen D., Becker H., de Haan L., Dingemans P.M., Birchwood M., Patterson P., Salokangas R.K., Heinimaa M., Heinz A., Juckel G., von Reventlow H.G., French P., Stevens H., Schultze-Lutter F., Klosterkötter J., Ruhrmann S. Disability in people clinically at high risk of psychosis. Br. J. Psychiatry 2010, 197(4):278-284.
17. Yung A.R., Phillips L.J., Yuen H.P., Francey S.M., McFarlane C.A., Hallgren M., McGorry P.D. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr. Res. 2003, 60(1):21-32.
18. Yung A.R., Phillips L.J., Yuen H.P., McGorry P.D. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr. Res. 2004, 67(2-3):131-142.
19. Yung A.R., Yuen H.P., McGorry P.D., Phillips L.J., Kelly D., Dell'Olio M., Francey S.M., Cosgrave E.M., Killackey E., Stanford C., Godfrey K., Buckby J. Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust. N. Z. J. Psychiatry 2005, 39(11-12):964-971.
20. Yung A.R., Buckby J.A., Cotton S.M., Cosgrave E.M., Killackey E.J., Stanford C., Godfrey K., McGorry P. Psychotic-like experiences in nonpsychotic help-seekers: associations with distress, depression, and disability. Schizophr. Bull. 2006, 32(2):352-359.